PT94042A - Processo para a preparacao de compostos antagonistas de aminoacidos estimulantes do complexo de receptores do acido n-metil-d-aspartico (nmda) e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de compostos antagonistas de aminoacidos estimulantes do complexo de receptores do acido n-metil-d-aspartico (nmda) e de composicoes farmaceuticas que os contem

Info

Publication number
PT94042A
PT94042A PT94042A PT9404290A PT94042A PT 94042 A PT94042 A PT 94042A PT 94042 A PT94042 A PT 94042A PT 9404290 A PT9404290 A PT 9404290A PT 94042 A PT94042 A PT 94042A
Authority
PT
Portugal
Prior art keywords
aminoacides
nmda
receptors
methyl
contain
Prior art date
Application number
PT94042A
Other languages
English (en)
Other versions
PT94042B (pt
Inventor
Bruce Michael Baron
Boyd Lynn Harrison
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT94042A publication Critical patent/PT94042A/pt
Publication of PT94042B publication Critical patent/PT94042B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT94042A 1989-05-16 1990-05-15 Processo para a preparacao de compostos antagonistas de aminoacidos estimulantes do complexo de receptores do acido n-metil-d-aspartico (nmda) e de composicoes farmaceuticas que os contem PT94042B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35242389A 1989-05-16 1989-05-16

Publications (2)

Publication Number Publication Date
PT94042A true PT94042A (pt) 1991-01-08
PT94042B PT94042B (pt) 1997-05-28

Family

ID=23385074

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94042A PT94042B (pt) 1989-05-16 1990-05-15 Processo para a preparacao de compostos antagonistas de aminoacidos estimulantes do complexo de receptores do acido n-metil-d-aspartico (nmda) e de composicoes farmaceuticas que os contem

Country Status (19)

Country Link
EP (1) EP0398283B1 (pt)
JP (1) JP3014001B2 (pt)
KR (1) KR0169107B1 (pt)
CN (1) CN1027369C (pt)
AT (1) ATE113597T1 (pt)
AU (1) AU626418B2 (pt)
DE (1) DE69013750T2 (pt)
DK (1) DK0398283T3 (pt)
ES (1) ES2066035T3 (pt)
FI (1) FI95795C (pt)
GR (1) GR3014893T3 (pt)
HU (1) HU214322B (pt)
IE (1) IE64671B1 (pt)
IL (1) IL94377A (pt)
NO (1) NO177141C (pt)
NZ (1) NZ233641A (pt)
PT (1) PT94042B (pt)
TW (1) TW207950B (pt)
ZA (1) ZA903588B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
AU660969B2 (en) * 1991-02-27 1995-07-13 Merrell Pharmaceuticals Inc. NMDA antagonists
GB9200781D0 (en) * 1992-01-15 1992-03-11 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
FR2722786B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
WO1997037999A1 (en) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
DE60022906T2 (de) 1999-12-28 2006-07-06 Eisai Co., Ltd. Heterozyklische verbindungen mit sulfonamid-gruppen
DE50207103D1 (en) * 2001-03-14 2006-07-20 Gruenenthal Gmbh Substituierte pyrazolo- und thiazolopyrimidine als analgetika
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
NZ589136A (en) 2008-04-11 2012-06-29 Merck Patent Gmbh Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2017121308A1 (en) * 2016-01-11 2017-07-20 Chongqing Fochon Pharmaceutical Co., Ltd. Fused pyridine compounds, compositions and methods of use
WO2018202039A1 (zh) * 2017-05-03 2018-11-08 成都海创药业有限公司 杂环化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563831B1 (fr) * 1984-05-04 1986-11-21 Sanofi Sa Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents

Also Published As

Publication number Publication date
DK0398283T3 (da) 1994-11-28
KR900018112A (ko) 1990-12-20
FI95795C (fi) 1996-03-25
NO902179D0 (no) 1990-05-15
NO177141B (no) 1995-04-18
FI95795B (fi) 1995-12-15
TW207950B (pt) 1993-06-21
ATE113597T1 (de) 1994-11-15
HUT54657A (en) 1991-03-28
DE69013750T2 (de) 1995-05-24
EP0398283A1 (en) 1990-11-22
ES2066035T3 (es) 1995-03-01
CN1027369C (zh) 1995-01-11
CN1047292A (zh) 1990-11-28
AU5491490A (en) 1990-11-22
KR0169107B1 (ko) 1999-01-15
DE69013750D1 (de) 1994-12-08
AU626418B2 (en) 1992-07-30
JPH0311067A (ja) 1991-01-18
IL94377A0 (en) 1991-03-10
FI902416A0 (fi) 1990-05-15
GR3014893T3 (en) 1995-05-31
NO177141C (no) 1995-07-26
NO902179L (no) 1990-11-19
HU903031D0 (en) 1990-09-28
JP3014001B2 (ja) 2000-02-28
NZ233641A (en) 1992-07-28
IE64671B1 (en) 1995-08-23
EP0398283B1 (en) 1994-11-02
HU214322B (hu) 1998-03-02
IE901750L (en) 1990-11-16
IL94377A (en) 1997-01-10
PT94042B (pt) 1997-05-28
ZA903588B (en) 1991-02-27

Similar Documents

Publication Publication Date Title
PT94042A (pt) Processo para a preparacao de compostos antagonistas de aminoacidos estimulantes do complexo de receptores do acido n-metil-d-aspartico (nmda) e de composicoes farmaceuticas que os contem
MX19448A (es) Procedimiento para la prreparacion de compuestos antagonistas de los receptores de aminoacidos excitadores; compuestos obtenidos y composicion farmaceutica que los incluye.
PT99400A (pt) Processo para a preparacao de derivados de 3-amido- e 3-sulfamido-indolilo e de composicoes farmaceuticas que os contem
PT93089A (pt) Processo para a preparacao de derivados do acido propenoico e de composicoes fungicidas que os contem
PT89661A (pt) Processo para a preparacao de compostos pirrolicos substituidos e de composicoes farmaceuticas que os contem
PT92502A (pt) Processo para a preparacao de compostos de pirimidina e de composicoes farmaceuticas que os contem
PT82941B (pt) Processo para a preparacao de esteres do acido hialuronico e de composicoes farmaceuticas que os contem
PT87958A (pt) Processo para a preparacao de composicoes farmaceuticas, contendo antagonistas 5ht-3
BR9002200A (pt) Utilizacao de derivados substituidos de amidas de aminoacidos,derivados substituidos,processo para sua preparacao,composicoes pesticidas,processo para o combate a parasitas e para a preparacao de composicoes
PT95448A (pt) Processo para a preparacao de derivados azotados inibidores de proteases retrovirais e de composicoes farmaceuticas que os contem
PT83186B (pt) Processo para a preparacao de uma modificacao estavel de1-isopropil-3-{(4-m-toluidino-3-piridil)-sulfonil}-ureia (torasemida) e de composicoes farmaceuticas que os contem
PT91287A (pt) Processo de preparacao de derivados do acido indazol-3-carboxilico e de composicoes farmaceuticas que os contem
PT94447A (pt) Processo para a preparacao de antagonistas tetrazolicos de receptores dos aminoacidos excitadores
PT89311A (pt) Processo para a preparacao de novos aminoalcoxi-p-benzonitrilos substituidos utilizaveis como agentes antiarritmicos e de composicoes farmaceuticas que os contem
PT88335A (pt) Processo para a preparacao de derivados do acido 1,4-dihidro-4-oxo-3-quinolinocarboxilico e de composicoes farmaceuticas que os contem
PT84064B (pt) Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem
PT89234A (pt) Processo para a preparacao de novos compostos de amonio e de composicoes farmaceuticas que os contem
PT94225A (pt) Processo para a preparacao de novos compostos derivados de cromano e de composicoes farmaceuticas que os contem
PT82901B (pt) Processo para a preparacao de derivados do acido antranilico dotados de accao terapeutica e de composicoes farmaceuticas que os contem
PT94792A (pt) Processo para a preparacao de novos compostos derivados de cromano e de composicoes farmaceuticas que os contem
PT91215A (pt) Processo para a preparacao de antagonistas de bombesina e de composicoes farmaceuticas que os contem
PT88041A (pt) Processo para a preparacao de derivados do acido hidrocinamico e de composicoes farmaceuticas que os contem
PT90530A (pt) Processo para a preparacao de derivados do acido 1,1-dioxo-cefem-4-carbotiolico e de composicoes farmaceuticas ou veterinarias que os contem
PT97692A (pt) Processo para a preparacao de derivados heterociclicos antagonistas de nmda (acido n-metil-d-aspartico)
PT80876B (pt) Processo para a preparacao de derivados do acido fenil-nonatetraenoico e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19970226

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040826